The Patent Finder

Terms ending in 2030

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,198,441Process for the Preparation of Novel Pyridopyrazines as Mtor Kinase Inhibitors
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 8,093,252Crystalline Polymorphic Form of Glucokinase Activator
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 8,101,623A Substituted Pyrrolo[2,3-d]pyrimidine as a Protein Kinase B Inhibitor
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 8,198,414Anti-Human IL-6 Antibodies
In force
 · High confidence
MedImmune LimitedIn forceHigh confidence
US 8,425,934Pharmaceutical Compositions
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 8,258,140Chemical Compounds - 643
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 9,533,978Novel Pyrimidine Derivatives and Their Use in the Treatment of Cancer and Further Diseases
In force
 · Medium confidence
Sumitomo Pharma Co., Ltd.In forceMedium confidence
US 8,685,934Methods for Treating Extreme Insulin Resistance in Patients Resistant to Previous Treatment with other Anti-Diabetic Drugs Employing an SGLT2 Inhibitor and Compositions Thereof
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 8,658,641Fused, Spirocyclic Heteroaromatic Compounds for the Treatment of Bacterial Infections
In force
 · High confidence
Entasis Therapeutics Inc.In forceHigh confidence
US 8,232,296Novel Salt 628
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
11 more term ends in 2030 · Pro
10 of 21 patents shown. Soonest term end first, then patent number.
Pro members see all 21.
Upgrade to Pro
13 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited